Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sahlgrenska Science Park is a Sweden-based life science innovation hub, accelerator, and science park focused on strengthening the life science and health innovation ecosystem in Gothenburg and West Sweden. Rather than developing its own therapeutic pipeline, it supports startups, scaleups, researchers, clinicians, and industry partners through the CO-AX Accelerator, Health Innovation Labs, community-building, and strategic partnership programs. The organization operates as a neutral collaboration arena linking academia, healthcare, industry, investors, and the public sector to advance commercialization and implementation of health innovations. Its emphasis spans healthtech, medtech, biotech, and broader life science company creation and growth. Sahlgrenska Science Park also provides shared lab and office infrastructure and plays an ecosystem-building role in regional life science development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sahlgrenska Science Park.